Alshaker, H., Wang, Q., Böhler, T., Mills, R., Winkler, M., Arafat, T., . . . Pchejetski, D. (2017). Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1. Sci Rep.
استشهاد بنمط شيكاغوAlshaker, Heba, Qi Wang, Torsten Böhler, Robert Mills, Mathias Winkler, Tawfiq Arafat, Yoshiaki Kawano, و Dmitri Pchejetski. "Combination of RAD001 (everolimus) and Docetaxel Reduces Prostate and Breast Cancer Cell VEGF Production and Tumour Vascularisation Independently of Sphingosine-kinase-1." Sci Rep 2017.
MLA استشهادAlshaker, Heba, et al. "Combination of RAD001 (everolimus) and Docetaxel Reduces Prostate and Breast Cancer Cell VEGF Production and Tumour Vascularisation Independently of Sphingosine-kinase-1." Sci Rep 2017.